|Articles|November 7, 2019
HCP monitoring in downstream process samples
Author(s)PharmaFluidics
µPAC™ technology has been used for analysing HCP impurities originating from recombinant expression systems used in the production of mAb based biotherapeutics.
Related Content
Trending on LCGC International
1
Challenges and Solutions in Oligonucleotide Analysis, Part IV – Solvent Mismatch, Denaturing vs. Non-Denaturing Conditions, and Non-Specific Adsorption
2
Tracking Soccer Player Hormones With LC-MS/MS
3
LC-MS Assists in Blood Test Targeting Lung Cancer Detection
4
LC-HRMS Tracks Pollutant Effects in Bay Mussels
5